
Self-Collection Testing Expands to New Areas: Elitza Theel, Ph.D.
Answers From the Lab
Published October 2, 2025
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, and Elitza Theel, Ph.D., director of the Infectious Diseases Serology Laboratory at Mayo Clinic, discuss the latest developments in self-collection testing for women’s health and beyond. Together, they explore:
- New podcast format launching (00:01): Dr. Pritt previews exciting changes coming to “Answers From the Lab.”
- Emerging self-collection tests (01:21): Explore the growing range of self-collection tests now available for use in both clinical settings and at home.
- Validation of self-collection tests (03:19): Learn how laboratorians validated recent self- and home-collection tests to ensure quality and accuracy.
- Benefits for patients and public health (06:56): Understand the benefits self-collection tests offer to patients and how the tests impact public health.
- Limitations and implementation considerations (08:23): Review key factors to consider when incorporating self-collection testing into clinical care.
- Future innovation (11:34): Insights into where self-collection testing may evolve in the years ahead.
Resources
Learn more The Impacts of STI Testing Innovation: Elitza Theel, Ph.D.
Learn more More on testing to support women’s health
Podcast episode
Note: Information in this post was accurate at the time of its posting.